iStent technology has revolutionised the treatment of glaucoma in Australia since its introduction in 2016. As the tiniest implantable device in the human body, and with over one million successful implantations worldwide, it has been a game changer for patients diagnosed with glaucoma by effectively reducing eye pressure and medication burden.
The latest addition to the iStent family – iStent infinite – is now available.
iStent infinite is designed to provide foundational, 24/7 therapy that gives you the power to deliver optimised treatment for patients with primary open angle glaucoma, currently treated with glaucoma medication – including those who have failed prior medical or surgical intervention – while minimising the unwanted side effects of more invasive treatment options.
iStent infinite is approved by the Therapeutics Goods Administration and on the prescribed list of medical devices.
Contact: Glaukos Account Manager
